NRx Pharma Stock Under Pressure On Equity Raise Of $30M
NRx Pharmaceuticals Inc (NASDAQ:NRXP) stock shed yesterday’s gains after announcing a private placement of 2.72 million shares. The purchase price…
Baidu Raises $1B Via Debt Offering
Baidu Inc (NASDAQ:BIDU) priced $300 million of 1.625% notes due 2027 and $700 million of 2.375% notes due 2031…
Cathie Wood Reduces Coinbase, Robinhood, Bitcoin-Related Holdings
Cathie Wood’s investment management firm ARK Invest has reduced its exposure to several crypto-related stocks and funds.
Cellectar Receives $2M NIH Grant For Rare Lymphoma Study
Cellectar Biosciences Inc (NASDAQ:CLRB) has received a peer-reviewed National Institutes of Health (NIH) Phase II Small Business Innovation Research…
MedMen Announces $100M Equity Investment On Heels Of Tilray Buying Its Convertible Debt, Deal Led By Serruya Private Equity
Cannabis retailer MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has secured $100 million in financing through a private placement of its units.
Trading.TV To Launch The Fintech Love Child Of Twitch And Slack After $6.1M Raise
Trading.TV, an online, social livestream community for investors, formally announced the closure of a $6.1 million seed round led by L Catterton Growth, Activant, Navy Capital and Tribe
Peter Thiel-Backed Crypto Exchange Bitpanda Raises $263M At $4.1B Valuation
Austria-based cryptocurrency exchange Bitpanda raised $263 million of funding, further increasing the firm's already sky-high valuation.
Gritstone Bio Enters Up To $20.6M Funding Agreement With Coalition For Epidemic Preparedness Innovations To Advance Gritstone’s CORAL COVID-19 Vaccine Program
CEPI to fund Gritstone's work on second-generation vaccines against SARS-CoV-2, the virus causing COVID-19, including a clinical trial in South Africa and manufacturing optimization
Gritstone's
Taysha Gene Secures $100M In Debt Financing For Support Pipeline Development
Taysha Gene Therapies Inc (NASDAQ:TSHA) has entered into a loan and security agreement with Silicon Valley Bank (SVB), providing up to $100 million…
RIV Capital Ends Q1 2022 With $212.5M On Hand After Announcing $150M Strategic Investment From Scotts Miracle-Gro’s Cannabis-Focused Subsidiary
Cannabis-focused venture capital firm RIV Capital Inc. (TSX: RIV) (OTC: CNPOF), formerly known as Canopy Rivers Inc., reported Monday that it has ended the first quarter of fiscal 2022 with CA$212.5 million ($169.7 million) of cash on hand.